Fig. 4From: Identification of predictors based on drug targets highlights accurate treatment of goserelin in breast and prostate cancerConducting clinical correlation analysis of CRABP2 by UALCAN. a CRABP2 transcription in subgroups of patients with breast cancer, stratified based on gender, age menopause status, disease stage, nodal metastasis status, and molecular subtypes. b CRABP2 transcription in subgroups of patients with prostate cancer, stratified based on age, gleason score, nodal metastasis status, and molecular signatureBack to article page